SNYR

$1.32

Market ClosedAs of Mar 17, 8:00 PM UTC

Synergy CHC Corp.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.32
Potential Upside
281.8%
Whystock Fair Value$5.04
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Distribution

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$14.85M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
4.71
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.27
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.61

Recent News

Zacks
Mar 17, 2026

HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates

HealthEquity (HQY) delivered earnings and revenue surprises of +7.09% and +0.52%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 10, 2026

Synergy CHC Insider Ups Holding During Year

From what we can see, insiders were net buyers in Synergy CHC Corp.'s ( NASDAQ:SNYR ) during the past 12 months. That...

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
GuruFocus.com
Nov 13, 2025

Synergy CHC Corp (SNYR) Q3 2025 Earnings Call Highlights: Growth in Revenue and Strategic ...

Despite a decline in net income, Synergy CHC Corp (SNYR) showcases robust revenue growth and strategic leadership moves to bolster future expansion.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Nov 10, 2025

DocGo Inc. (DCGO) Reports Q3 Loss, Beats Revenue Estimates

Motion Acquisition (DCGO) delivered earnings and revenue surprises of -22.22% and +0.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Oct 2, 2025

At US$2.50, Is Synergy CHC Corp. (NASDAQ:SNYR) Worth Looking At Closely?

Synergy CHC Corp. ( NASDAQ:SNYR ), might not be a large cap stock, but it saw a double-digit share price rise of over...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.